STOCK TITAN

AtriCure (ATRC) Rule 144 Notice: 5,000 Shares to Be Sold via Morgan Stanley

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A person affiliated with AtriCure, Inc. (ATRC) intends to sell 5,000 shares of the company's common stock through Morgan Stanley Smith Barney LLC on the NASDAQ. The notice lists an approximate sale date of 08/19/2025 and an aggregate market value of $180,000 based on that sale. The shares were acquired on 08/19/2025 through a stock option exercise from the issuer and payment was made in cash. The filer reports no securities sold in the past three months for the account covered by this notice and includes the standard representation that the seller does not possess undisclosed material information about the issuer.

Positive

  • Disclosure compliance: The filer provided required Rule 144 details including broker, quantity, acquisition method, and sale timing.
  • No recent sales: The notice states there were no securities sold in the past three months for the account covered.

Negative

  • Insider sale reported: The person for whose account the notice is filed intends to sell 5,000 common shares.
  • Potential dilution context provided: The filing lists 49,701,415 shares outstanding, giving scale to the sale quantity.

Insights

TL;DR: Routine Rule 144 notice disclosing a small, open-market sale following a stock option exercise.

This Form 144 provides required public disclosure for an intended sale under Rule 144. It identifies the broker, the class and quantity of shares, the acquisition method as a stock option exercise, cash payment, and an approximate sale date. The statement that there were no sales in the prior three months and the seller's representation about material nonpublic information are standard compliance elements that allow market participants to assess adherence to resale conditions.

TL;DR: Small insider sale that is unlikely to affect company fundamentals given the share quantity disclosed.

The filing documents an intended sale of 5,000 common shares with an aggregate market value of $180,000 and shows total shares outstanding of 49,701,415. The shares were acquired via option exercise and are to be sold through a retail broker on NASDAQ. This disclosure is informative for monitoring insider activity but does not, by itself, convey operational or earnings information about the company.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for ATRC disclose about the planned sale?

The Form 144 discloses an intended sale of 5,000 common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $180,000.

How were the shares being sold acquired according to the filing?

The shares were acquired on 08/19/2025 by a stock option exercise from the issuer, with payment made in cash.

Does the filing report any other recent sales by the same person?

No. The filing explicitly states Nothing to Report for securities sold during the past three months.

What broker will execute the sale listed in the Form 144 for ATRC?

The sale is to be executed by Morgan Stanley Smith Barney LLC, Executive Financial Services, New York, NY.

What is the approximate date of the proposed sale?

The Form 144 lists the approximate date of sale as 08/19/2025.

How many shares outstanding does the filing show, and why does that matter?

The filing lists 49,701,415 shares outstanding; this provides context to assess the relative size of the 5,000-share sale.